Search alternatives:
significant event » significant effect (Expand Search), significant level (Expand Search), significant effects (Expand Search)
event decrease » cement decreases (Expand Search), point decrease (Expand Search), levels decreased (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), step decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
significant event » significant effect (Expand Search), significant level (Expand Search), significant effects (Expand Search)
event decrease » cement decreases (Expand Search), point decrease (Expand Search), levels decreased (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), step decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1601
-
1602
-
1603
-
1604
Each subfigure shows a different local size (LS) and context size (CS) configuration, where the reliability of the model across different initializations is measured in R-squared.
Published 2025“…<p>In most cases where both the local size and context size is small, the DSVAE model is significantly more reliable than the IDSVAE method. However, for a local size of 8, the IDSVAE method is significantly more reliable when the context sizes are 2 or 8. …”
-
1605
-
1606
-
1607
-
1608
-
1609
Treatment consequence and adverse events of cyclin-dependent kinase 4/6 inhibitors on patients with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic...
Published 2025“…</p> <p>Eleven clinical trials published between 2015 and 2022 were included in our meta-analysis, with a total of 5572 eligible patients. This meta-analysis found that HR(+)/HER2(−) metastatic breast cancer treated with CDK4/6 inhibitors plus endocrine therapy can significantly improve progression-free survival(PFS) (HR: 0.55; <i>p</i> < 0.001), overall survival (OS) (HR: 0.79; <i>p</i> < 0.001), objective response rate (RR = 1.50; <i>p</i> < 0.001), clinical benefit rate (RR = 1.18; <i>p</i> < 0.001) and decrease progressive disease rate (RR = 0.49; <i>p</i> < 0.001). …”
-
1610
-
1611
Image 1_L-shaped association of triglyceride glucose-body mass index and self-rated mental health among the middle-aged and older adults: a national cohort study in China.tiff
Published 2025“…Below this threshold, each 10-unit increase in TyG-BMI was associated with a 6% decrease in self-rated mental health risk (adjusted hazard ratio [aHR] = 0.94, 95% confidence interval [CI]: 0.90–0.99). …”
-
1612
Image 2_L-shaped association of triglyceride glucose-body mass index and self-rated mental health among the middle-aged and older adults: a national cohort study in China.tiff
Published 2025“…Below this threshold, each 10-unit increase in TyG-BMI was associated with a 6% decrease in self-rated mental health risk (adjusted hazard ratio [aHR] = 0.94, 95% confidence interval [CI]: 0.90–0.99). …”
-
1613
-
1614
-
1615
-
1616
-
1617
Summary of study eligibility criteria.
Published 2025“…In addition, a panel of safety blood markers measured pre- and post-intervention confirmed no clinically significant changes in blood chemistry or blood cell count.…”
-
1618
Summary of study participation and feasibility.
Published 2025“…In addition, a panel of safety blood markers measured pre- and post-intervention confirmed no clinically significant changes in blood chemistry or blood cell count.…”
-
1619
-
1620